Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects

Completed · Phase 1

Conditions studied: Schizophrenia

In brief

This study is being conducted to evaluate the safety and tolerability of ascending multiple oral doses of SCA-136 adminstered to healthy Japanese and non-Japanese female subjects.

Key facts

Study ID

NCT00458107

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

64

Starts

2007-04-01

Expected to finish

2007-09-01

Last updated by the study team

2007-12-05

Who can join

Age: 20 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Healthy Japanese women or non-Japanese of child bearing potential using nonhormonal contraceptives.
• Japanese female subjects are defined as being born in Japan but living outside of Japan for less than 5 years.

You may not qualify if…

• Any significant disease.
• Positive urine drug screen, increased liver funtion tests, use of prescription drugs.

Where it is running

• Study site — Glendale, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.